Soluble Interleukin-2 Receptors in Systemic Lupus Erythematosus

Overview

Journal Arthritis Rheum

Specialty Rheumatology

Date 1988 Jun 1

PMID 3132927

Citations 51

Authors

R E Wolf

W G Brelsford

Affiliations

Soon will be listed here.

Abstract

We studied levels of soluble interleukin-2 receptors (IL-2R), which are released by activated lymphocytes, in 139 serum samples from 12 patients with systemic lupus erythematosus (SLE). Concentrations of soluble IL-2R were significantly increased in SLE patients compared with controls (P less than 0.001), and they were significantly higher in patients during active SLE defined by low C3 levels (P less than 0.001), low C4 levels (P less than 0.001), or proteinuria (P less than 0.05) than during inactive SLE. Elevated levels of soluble IL-2R correlated with hypocomplementemia in longitudinal studies (P less than 0.001). Measurement of serum concentrations of soluble IL-2R may provide a sensitive and specific method for monitoring disease activity and immune activation in patients with SLE.

Citing Articles

A framework for exclusion of alternative diagnoses in sarcoidosis.

Harper L, Farver C, Yadav R, Culver D J Autoimmun. 2024; 149:103288.

PMID: 39084998 PMC: 11791745. DOI: 10.1016/j.jaut.2024.103288.

Subcutaneous sarcoidosis: a clinical analysis of nine patients.

Ando M, Miyazaki E, Hatano Y, Nishio S, Torigoe C, Yamasue M Clin Rheumatol. 2016; 35(9):2277-81.

PMID: 27449952 DOI: 10.1007/s10067-016-3356-0.

Role of T-Cell Polarization and Inflammation and Their Modulation by n-3 Fatty Acids in Gestational Diabetes and Macrosomia.

Hichami A, Grissa O, Mrizak I, Benammar C, Khan N J Nutr Metab. 2016; 2016:3124960.

PMID: 27313878 PMC: 4897714. DOI: 10.1155/2016/3124960.

Increased level of tumor necrosis factor-α in patients with antiphospholipid syndrome: marker not only of inflammation but also of the prothrombotic state.

Swadzba J, Iwaniec T, Musial J Rheumatol Int. 2009; 31(3):307-13.

PMID: 20012959 DOI: 10.1007/s00296-009-1314-8.

Biomarkers as tools for improved diagnostic and therapeutic monitoring in systemic lupus erythematosis.

Smith Jr M, Hiepe F, Dorner T, Burmester G Arthritis Res Ther. 2009; 11(6):255.

PMID: 19939293 PMC: 3003542. DOI: 10.1186/ar2834.